Auna (NYSE:AUNA – Get Free Report) and INVO Fertility (NASDAQ:IVF – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, analyst recommendations, profitability, institutional ownership and earnings.
Profitability
This table compares Auna and INVO Fertility’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Auna | 0.44% | 12.88% | 3.24% |
| INVO Fertility | -116.29% | -85.54% | -31.05% |
Analyst Ratings
This is a breakdown of current recommendations and price targets for Auna and INVO Fertility, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Auna | 1 | 2 | 1 | 1 | 2.40 |
| INVO Fertility | 1 | 0 | 0 | 1 | 2.50 |
Auna presently has a consensus target price of $6.97, indicating a potential upside of 29.98%. INVO Fertility has a consensus target price of $20.00, indicating a potential upside of 3,486.80%. Given INVO Fertility’s stronger consensus rating and higher possible upside, analysts plainly believe INVO Fertility is more favorable than Auna.
Volatility and Risk
Auna has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.39, suggesting that its share price is 139% more volatile than the S&P 500.
Valuation and Earnings
This table compares Auna and INVO Fertility”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Auna | $1.23 billion | 0.32 | $27.39 million | $0.07 | 76.57 |
| INVO Fertility | $7.53 million | 0.19 | -$25.13 million | ($33.83) | -0.02 |
Auna has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
12.0% of INVO Fertility shares are held by institutional investors. 0.4% of INVO Fertility shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Auna beats INVO Fertility on 9 of the 14 factors compared between the two stocks.
About Auna
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
About INVO Fertility
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
